Literature DB >> 2847350

Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.

B Smedsrød1, M Einarsson, H Pertoft.   

Abstract

Experiments were carried out to characterize the specificity of uptake of tPA in rat liver cells. Endocytosis in liver endothelial cells of the native carbohydrate variants of tissue plasminogen activator (tPA), and tPA inactivated by diisopropyl fluorophosphate was found to be competitive, suggesting that the determinant being recognized by these cells is different from the active site. Fibronectin and urokinase, which show partial homology with tPA, did not compete with tPA for uptake in liver endothelial cells. Hyaluronic acid, collagen, or IgG, which are endocytosed by specific receptors in liver endothelial cells, did not interfere with the uptake. Reduced endocytosis by liver endothelial cells was observed with tPA modified in the carbohydrate side chains, suggesting that these structures are important for uptake. Ovalbumin, mannan, mannose, fructose, and EDTA, but not galactose, effectively inhibited uptake in liver endothelial cells of both native and diisopropyl fluorophosphate-inhibited tPA, but had very little effect on the uptake of tPA modified in the carbohydrate side chains. Endocytosis of native tPA by parenchymal cells could be inhibited by galactose, ovalbumin, and EDTA, but not by mannose. These results suggest that endocytosis of tPA by liver endothelial cells and parenchymal cells is mediated by the mannose and galactose receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847350

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Scavenger functions of the liver endothelial cell.

Authors:  B Smedsrød; H Pertoft; S Gustafson; T C Laurent
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

2.  Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells.

Authors:  G M Kindberg; S Magnusson; T Berg; B Smedsrød
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

3.  Clinical glycomics in the diagnostic laboratory.

Authors:  Merel A Post; Dirk J Lefeber
Journal:  Ann Transl Med       Date:  2019-09

4.  Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.

Authors:  P Fitch; B Bennett; N A Booth; A Croll; S W Ewen
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo.

Authors:  E Stang; J Krause; W Seydel; T Berg; N Roos
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

6.  Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

Authors:  J Krause; W Seydel; G Heinzel; P Tanswell
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

7.  Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli.

Authors:  U Martin; S Fischer; U Kohnert; U Opitz; R Rudolph; G Sponer; A Stern; K Strein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

8.  Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.

Authors:  E Stang; N Roos; M Schlüter; T Berg; J Krause
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.

Authors:  M Otter; J Kuiper; R Bos; D C Rijken; T J van Berkel
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.